ProPhase Labs announced it will be giving a data presentation at the United States and Canadian Academy of Pathology, which is being held March 11 – 16, 2023, at the Ernest N. Morial Convention Center in New Orleans, LA. The senior author of the presentation is Christopher P. Hartley, MD of the Mayo Clinic, a board-certified pathologist, and principal investigator of the Collaborative Research Agreement with the Mayo Clinic to assess the performance of the Company’s BE-smart Test that detects and quantifies hallmarks of cancer development in tissue of patients diagnosed with Barrett’s esophagus, a precancerous condition with high incidence in the United States. The Director of Norton Thoracic Institute, Dr. Sumeet Mittal, Dr. Catherine Hagen of the Mayo Clinic, Dr. Sheeno Thyparambil of mProbe Inc. and Dr. Joe Abdo, scientific advisor to ProPhase Labs, serve as co-authors of the study. Dr. Andrew Cannon, an anatomic and clinical pathology resident at the Mayo Clinic serves as first author and will be giving the presentation to attendees of USCAP on Tuesday, March 14th.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PRPH:
- ProPhase Labs’ Nebula Genomics introduces lowest NGS pricing
- DSS ProPhase Labs announces letter to shareholders
- ProPhase Labs announces collaboration with mProbe
- ProPhase Labs announces plans to initiate clinical trial of Equivir OTC
- ProPhase Labs announces its BE-smart featured in peer-reviewed article